UGUlrika Gillespie

Ulrika Gillespie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ulrika Gillespie has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Patient Perspectives of Clinical Pharmacist Services in Hospitals and Clinics: A Focused Narrative Review of Qualitative Studies

    by Ben Tore Henriksen, Ulrika Gillespie, Liv Mathiesen, Yvonne Andersson

    Patient perspectives are highly important to ensure optimal patient care in hospitals or primary care settings. Clinical pharmacy services, in which clinical pharmacists provide direct patient care, are a relatively recent addition to healthcare and are increasing in scope and availability. In this focused narrative review, relevant qualitative studies describing patients' perspectives after the integration of clinical pharmacists into healthcare services were included. Patients described predominantly positive feedback, presented as facilitators. The facilitators described in studies were that patients felt safe , experienced clear communication and collaboration with pharmacists, increased their knowledge of medications, and appreciated pharmacists' time and availability . Occasionally, patients described challenges with the pharmacist or service, presented as barriers. The barriers were that patients were unfamiliar with the clinical pharmacists' role and services , lacked trust or experienced conflicting information , experienced a lack of patient‐centredness , and some disagreed or had challenges with elements of the intervention . In conclusion, most perspectives represented positive facilitators that should be kept and protected in the future, with some barriers that can be overcome in the future for optimal patient care and development of clinical pharmacy services.

  • Open Access

    Identifying potentially inappropriate prescribing in entire populations: coding the STOPP-START and Beers criteria for use with large, routinely collected population health datasets

    by Lise M. Bjerre, Roland Halil, Christina Catley, Glenys Smith, Timothy Ramsay, Caitriona Cahir, Cristín Ryan, Barbara Farrell, Kednapa Thavorn, Steven Hawken, et al.


  • Open Access

    Prevalence and predictors of potentially inappropriate prescribing using codified STOPP-START and Beers criteria: a retrospective cohort study in Ontario's older population

    by Lise M. Bjerre, Christina Catley, Glenys Smith, Roland Halil, Timothy Ramsay, Catriona Cahir, Cristín Ryan, Barbara Farrell, Kednapa Thavorn, Steven Hawken, et al.


  • Open Access

    4CPS-174 Facilitators and barriers to performing comprehensive medication reviews and follow-up in older hospitalised patients by multiprofessional ward teams including a clinical pharmacist

    by T Kempen, A Kälvemark, M Sawires, D Stewart, U Gillespie

    Background and importance There is a lack of knowledge about factors that influence the performance of comprehensive medication reviews (CMRs) and post-discharge follow-up by multiprofessional ward teams including a clinical pharmacist. A better understanding of these factors is needed to support implementation and sustainability of CMRs or similar services by clinical pharmacists in hospital practice. Aim and objectives This study aimed to explore the facilitators and barriers to performing CMRs and post-discharge follow-up in older hospitalised patients. Material and methods Physicians and clinical pharmacists were recruited from an ongoing trial at eight internal medicine or geriatric wards in four hospitals in Sweden. Semi-structured interviews were conducted with 16 physicians and 7 pharmacists. Interview topics were: working processes, resources, competences, medication related problems, intervention effects and collaboration. The interviews were audio recorded, transcribed verbatim and thematically analysed using the Consolidated Framework for Implementation Research (CFIR). Identified subthemes were categorised as facilitators or barriers and grouped into overarching main themes. Results In total, 24 facilitators and 25 barriers were identified across all CFIR domains and grouped into six main themes: (a) CMRs and follow-up are needed, but not in all patients; (b) there is a general belief in positive effects; (c) lack of resources is an issue, although the performance of CMRs may save time; (d) pharmacists’ knowledge and skills are valuable, but they need more clinical competence; (e) compatibility with hospital practice is challenging, and roles and responsibilities are unclear; and (f) personal contact on the ward is essential for physician–pharmacist collaboration. Conclusion and relevance Multiple facilitators and barriers for performing CMRs and post-discharge follow-up in older hospitalised patients exist. These factors should be addressed in future initiatives with similar interventions by multiprofessional teams including a clinical pharmacist to ensure successful implementation and sustainability in hospital practice. References and/or acknowledgements We would like to thank all physicians and pharmacists who participated in this study. No conflict of interest.


  • Open Access

    Intervention fidelity and process outcomes of medication reviews including post‐discharge follow‐up in older hospitalized patients: Process evaluation of the MedBridge trial

    by Thomas G. H. Kempen, Henrik Cam, Amanda Kälvemark, Karl‐Johan Lindner, Håkan Melhus, Elisabet I. Nielsen, Johanna Sulku, Ulrika Gillespie

    What is known and objective Drug‐related problems (DRPs) are a growing healthcare burden worldwide. In an ongoing cluster‐randomized controlled trial in Sweden (MedBridge), comprehensive medication reviews (CMRs) including post‐discharge follow‐up have been conducted in older hospitalized patients to prevent and solve DRPs. As part of a process evaluation of the MedBridge trial, this study aimed to assess the intervention fidelity and process outcomes of the trial's interventions. Methods For intervention delivery, the percentage of patients that received intervention components was calculated per study group. Process outcomes, measured in about one‐third of all intervention patients, included the following: the number of identified medication discrepancies, DRPs and recommendations to solve DRPs, correction rate of discrepancies, and implementation rate of recommendations. Results and discussion The MedBridge trial included 2637 patients (mean age: 81 years). The percentage of intervention patients (n = 1745) that received the intended intervention components was 94%‐98% during admission, and 40%‐81% upon and after discharge. The percentage of control patients (n = 892) that received at least one unintended intervention component was 15%. On average, 1.1 discrepancies and 2.0 DRPs were identified in 652 intervention patients. The correction and implementation rates were 79% and 73%, respectively. Stop medication was the most frequently implemented recommendation (n = 293) and 77% of the patients had at least one corrected discrepancy or implemented recommendation. What is new and conclusion The intervention fidelity within the MedBridge trial was high for CMRs during hospital stay and lower for intervention components upon and after discharge. The high prevalence of corrected discrepancies and implemented recommendations may explain potential effects of CMRs in the MedBridge trial.


  • Open Access

    Facilitators and barriers for performing comprehensive medication reviews and follow-up by multiprofessional teams in older hospitalised patients

    by Thomas Gerardus Hendrik Kempen, Amanda Kälvemark, Maria Sawires, Derek Stewart, Ulrika Gillespie

    Purpose: There is a lack of knowledge about factors that influence the performance of comprehensive medication reviews (CMRs) by multiprofessional teams in hospital practice. This study aimed to explore the facilitators and barriers for performing CMRs and post-discharge follow-up in older hospitalised patients from the healthcare professional perspective. Methods: Physicians and ward-based pharmacists were recruited from an ongoing trial at four hospitals in Sweden. Semi-structured interviews were conducted with 16 physicians and 7 pharmacists. Interview topics were working processes, resources, competences, medication-related problems, intervention effects and collaboration. The interviews were audio-recorded, transcribed verbatim and thematically analysed using the Consolidated Framework for Implementation Research (CFIR). Identified subthemes were categorised as facilitators or barriers and grouped into overarching main themes. Results: In total, 21 facilitators and 25 barriers were identified across all CFIR domains and grouped in 6 main themes: (a) CMRs and follow-up are needed, but not in all patients; (b) there is a general belief in positive effects; (c) lack of resources is an issue, although the performance of CMRs may save time; (d) pharmacists’ knowledge and skills are valuable, but they need more clinical competence; (e) compatibility with hospital practice is challenging, and roles and responsibilities are unclear and (f) personal contact at the ward is essential for physician-pharmacist collaboration. Conclusion: Multiple facilitators and barriers for performing CMRs and post-discharge follow-up in older hospitalised patients exist. These factors should be addressed in future initiatives with similar interventions by multiprofessional teams to ensure successful implementation and performance in hospital practice.


  • Open Access

    Comprehensive medication reviews by ward‐based pharmacists in Swedish hospitals: What does the patient have to say?

    by Thomas G.H. Kempen, Amanda Kälvemark, Ulrika Gillespie, Derek Stewart

    Rationale, aims, and objectives: Inappropriate medication prescribing and use amongst older patients is a major patient safety and health care problem. To promote appropriate medication prescribing and use, comprehensive medication reviews (CMRs) by ward‐based pharmacists, including follow‐up telephone calls after hospital discharge, have been conducted in older patients in the context of a randomized controlled trial (RCT). One of the key actors in a CMR is the patient. To support the understanding of the effects of CMRs on patients' health outcomes and improve clinical practice, knowledge about the patient perspective is needed. We therefore aimed to explore older patients' experiences with, and views on, hospital‐initiated CMRs and follow‐up telephone calls by ward‐based clinical pharmacists within an RCT.Methods: We conducted in‐depth semi‐structured interviews with 15 patients (66‐94 years) and carers from four hospitals in Sweden. Discussion topics included communication, information, decision‐making, and effects on the patient. Interviews took place after discharge, were audio‐recorded, transcribed verbatim, and thematically analysed using a framework approach.Results: In general, patients' experiences and views were positive. Seven key themes were identified: (a) feeling of being taken care of and heterogenous health effects; (b) the pharmacist is competent; (c) despite the unclear role of pharmacists, their involvement is appreciated; (d) patients rely on health care professionals for decision‐making; (e) importance of being informed, but receiving and retaining information is problematic; (f) time, location, and other factors influencing the effectiveness of CMRs; and (g) generic substitution is a problem.Conclusions: Older patients generally have positive experiences with and views on CMRs and follow‐up telephone calls. However, some factors, like the unclear role of the ward‐based pharmacist and problems with receiving and retaining information, may negatively impact the effectiveness of these interventions. Future initiatives on hospital‐initiated CMRs by clinical pharmacists should address these negative factors and utilize the positive views.


  • Open Access

    Assessment tool for hospital admissions related to medications: development and validation in older patients

    by Thomas G. H. Kempen, Mariann Hedström, Hanna Olsson, Amanda Johansson, Sara Ottosson, Yousif Al-Sammak, Ulrika Gillespie


  • Activities performed by pharmacists integrated in family health teams: Results from a web-based survey

    by Ulrika Gillespie, Lisa Dolovich, Simone Dahrouge

    Objectives: Family health teams (FHTs), an interprofessional primary care practice model, were established in Ontario in 2005. As of October 2014, 191 FHT organizations were in operation, and 111 (58%) included one or several pharmacists. The objective of this study was to document the focus of pharmacist activities in FHTs. Approach: We invited all 155 known FHT pharmacists to a web-based survey. The survey was constructed using information obtained from previously done semi-structured telephone interviews with pharmacists working in FHTs. The survey consisted of a list of activities, grouped into 5 main categories, and participants were asked to estimate time spent on each category. Free-text response questions allowed participants to identify activities not listed. Survey results were analyzed using descriptive statistics and content analysis for open-ended responses. Results: Seventy (45%) pharmacists completed the survey. The mean respondent age was 43 years, and the average length of time working in an FHT was 4 years. All pharmacists reported being engaged in some form of direct patient care, including managing single therapeutic issues (96%), conducting general medication reviews (70%) and medication reconciliation after hospitalization (63%). Most reported providing education and drug information (83%). Pharmacists felt their work would increase patient medication adherence (94%) and physician adherence to recommended guidelines (86%), as well as reduce inappropriate prescribing (93%), polypharmacy (90%), emergency room and hospital utilization (70%-81%). Conclusion: Pharmacists in FHTs are strongly focused on direct patient care activities, managing specific medication issues and unstructured drug information to physicians. The majority of pharmacists reported that their activities had a substantial impact on patient medication use and health. The findings from this survey can assist pharmacists new to FHT practice, health policy planning and health research to assess associations between pharmacist activities and measures of health and health care system performance.


  • Open Access

    Effects of Pharmacists' Interventions on Appropriateness of Prescribing and Evaluation of the Instruments' (MAI, STOPP and STARTs') Ability to Predict Hospitalization–Analyses from a Randomized Controlled Trial

    by Ulrika Gillespie, Anna Alassaad, Margareta Hammarlund-Udenaes, Claes Mörlin, Dan Henrohn, Maria Bertilsson, Håkan Melhus

    Background Appropriateness of prescribing can be assessed by various measures and screening instruments. The aims of this study were to investigate the effects of pharmacists' interventions on appropriateness of prescribing in elderly patients, and to explore the relationship between these results and hospital care utilization during a 12-month follow-up period. Methods The study population from a previous randomized controlled study, in which the effects of a comprehensive pharmacist intervention on re-hospitalization was investigated, was used. The criteria from the instruments MAI, STOPP and START were applied retrospectively to the 368 study patients (intervention group (I) n = 182, control group (C) n = 186). The assessments were done on admission and at discharge to detect differences over time and between the groups. Hospital care consumption was recorded and the association between scores for appropriateness, and hospitalization was analysed. Results The number of Potentially Inappropriate Medicines (PIMs) per patient as identified by STOPP was reduced for I but not for C (1.42 to 0.93 vs. 1.46 to 1.66 respectively, p<0.01). The number of Potential Prescription Omissions (PPOs) per patient as identified by START was reduced for I but not for C (0.36 to 0.09 vs. 0.42 to 0.45 respectively, p<0.001). The summated score for MAI was reduced for I but not for C (8.5 to 5.0 and 8.7 to 10.0 respectively, p<0.001). There was a positive association between scores for MAI and STOPP and drug-related readmissions (RR 8–9% and 30–34% respectively). No association was detected between the scores of the tools and total re-visits to hospital. Conclusion The interventions significantly improved the appropriateness of prescribing for patients in the intervention group as evaluated by the instruments MAI, STOPP and START. High scores in MAI and STOPP were associated with a higher number of drug-related readmissions.